Peptilex – The Peptide Encyclopedia
- 34 peptides – from semaglutide to BPC-157 – in one book
- An evidence grade (A–E) and the key studies for every peptide
- Where each one stands in 2026 – US, EU and Switzerland
Brain & mood
DSIP (emideltide)
- Type
- Nine-amino-acid peptide ("delta sleep–inducing peptide")
- Main use or focus
- Sleep; stress; withdrawal symptoms
- Also known as
- Emideltide
Key studies from the book
Discovery and characterization of DSIP.
Schoenenberger GA, Monnier M – Proceedings of the National Academy of Sciences, 1977Five double-blind human studies; well tolerated, promoted sleep and normalized disturbed sleep in insomnia.
Schneider-Helmert D, Schoenenberger GA – Neuropsychobiology, 1983
All key studies, risks and open questions are in the book.
Research at a glance
All papers463
Human studies111
Animal studies only322
Randomized trials6
Meta-analyses & systematic reviews0
Source: PubMed and ClinicalTrials.gov via the Peptilex study database
Go deeper
Full profile in the book
What it is, how it acts, the key studies, risks and open questions.
Registered trials
ClinicalTrials.gov · name in study title · ongoing first
No registered trial yet on ClinicalTrials.gov.
Latest key papers
PubMed · newest first
- 2016
Human RCTZhao L et al. · European Spine JournalPMID 26931331
- 2009
Human RCTPomfrett CJ et al. · European Journal of AnaesthesiologyPMID 19142086
- 1994
Human RCTChiodera P et al. · Hormone ResearchPMID 7698722
- 1992
Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study
Human RCTBes F et al. · NeuropsychobiologyPMID 1299794
- 1981
Synthetic delta-sleep-inducing peptide improves sleep in insomniacs
Human RCTSchneider-Helmert D et al. · The LancetPMID 6112579